Dyne Therapeutics, Inc. (DYN) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 3.06B USD. 52-week range 13.72 to 27.30 USD. Data as of 2026-10-09.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers ...